Key Insights

Highlights

Success Rate

87% trial completion (above average)

Published Results

56 trials with published results (21%)

Research Maturity

167 completed trials (62% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

8.9%

24 terminated out of 269 trials

Success Rate

87.4%

+0.9% vs benchmark

Late-Stage Pipeline

24%

64 trials in Phase 3/4

Results Transparency

34%

56 of 167 completed with results

Key Signals

56 with results87% success24 terminated

Data Visualizations

Phase Distribution

216Total
Not Applicable (94)
Early P 1 (2)
P 1 (30)
P 2 (26)
P 3 (20)
P 4 (44)

Trial Status

Completed167
Unknown40
Terminated24
Recruiting13
Not Yet Recruiting9
Withdrawn7

Trial Success Rate

87.4%

Benchmark: 86.5%

Based on 167 completed trials

Clinical Trials (269)

Showing 20 of 20 trials
NCT07607041Not Yet RecruitingPrimary

Evolution of Physical Frailty and Patient-Reported Outcome Measures in Kidney Transplant Candidates: A Mixed-Methods Longitudinal Study Protocol

NCT07607197Phase 1RecruitingPrimary

Immunological Reset to Enable Access to Hla-compatible Kidney Transplantation in Highly Sensitized Patients (RESET)

NCT07612124Not ApplicableCompletedPrimary

Evaluation of the Application of Intelligent Applications in Patients Undergoing Peritoneal Dialysis

NCT05687058Phase 1Active Not RecruitingPrimary

Empagliflozin in ESKD - A Feasibility Study

NCT04876963CompletedPrimary

HOLT-ED: Holter-monitoring in End-stage Renal Disease

NCT06438445Not ApplicableRecruitingPrimary

Effects of Royal Jelly Supplementation in Chronic Kidney Disease

NCT04466865Not ApplicableCompleted

A Communication Tool to Assist Older Adults Facing Dialysis Choices

NCT01893710RecruitingPrimary

International (Pediatric) Peritoneal Biobank

NCT07544797Not ApplicableNot Yet Recruiting

Pea Fibre in Hemodialysis

NCT07531186Not ApplicableCompleted

Probiotic and Synbiotic Supplements in Hemodialysis Patients

NCT03640026Phase 4TerminatedPrimary

Glucose Disorders Induced by Tacrolimus on Pre Transplantation Endstage Renal Disease Patients

NCT04128189Phase 3Recruiting

Shingrix in Renal Transplant Recipients

NCT06217302Phase 3Recruiting

Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease

NCT06910475Not ApplicableEnrolling By Invitation

Physical Exercise and Biomolecular Analysis to Reduce Uremic Toxins in Chronic Kidney Disease: An Exploratory Study

NCT07426380Phase 1Recruiting

A Study of Eloralintide (LY3841136) in Participants With Renal Impairment and in Participants With Normal Renal Function

NCT00026702Terminated

Search for New Methods to Detect Acute Renal Failure

NCT05027074Phase 2Completed

Global Study of MK-2060 (Anti-Factor XI Monoclonal Antibody) in Participants With End Stage Renal Disease Receiving Hemodialysis (FXI Hemodialysis Study) (MK-2060-007)

NCT07358195Early Phase 1Not Yet RecruitingPrimary

Addition of Venetoclax to Combined Hematopoietic Stem Cell and Kidney Transplantation

NCT01380847Completed

Prediction of Chronic Allograft Nephropathy

NCT02722096Not ApplicableCompletedPrimary

Creation of Arteriovenous Ante-brachial Fistula Under Axillary Block Versus Local Anesthesia : Impact on Early Complications

Scroll to load more

Research Network

Activity Timeline